Senegal-made sickle cell treatment raises hopes, reduces costs
Senegal has taken a major step in the fight against sickle cell disease after pharmaceutical company Teranga Pharma began locally manufacturing DREPAF, a generic version of hydroxyurea used to manage the inherited blood disorder. The development is being celebrated as…